Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis

08-14-2007 | Categories:

Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
Sripal Bangalore MD, MHAa, Gayathri Kamalakkannan MD, MPHa, Sanobar Parkar MD, MPHa and Franz H. Messerli MD,
Am J Med. 2007 Aug;120(8):713-719





The Study

The authors found, via MEDLINE search, only 9 studies which met inclusion criteria: fixed-dose combination versus free-drug components of the regimen given separately were compared and compliance was reported. Two studies were in patients with tuberculosis, 4 in the hypertensive population, 1 in patients with human immunodeficiency virus (HIV) disease and 2 in the diabetic population. A total of 11,925 patients on fixed-dose combination were compared against 8317 patients on free-drug component regimen.

Results [excerpted from abstract]

Fixed-dose combination resulted in a 26% decrease in the risk of non-compliance compared with free-drug component regimen (pooled relative risk [RR] 0.74; 95% confidence interval [CI], 0.69-0.80; P less than .0001). There was no evidence of heterogeneity in this analysis (χ2 = 14.49, df = 8; P = .07). A subgroup analysis of the 4 studies on hypertension showed that fixed-dose combination (pooled RR 0.76; 95% CI, 0.71-0.81; P less than .0001) decreased the risk of medication non-compliance by 24% compared with free-drug combination regimen.

Commentary

This is a straight-forward study with results that lends additional support the notion that simplification of medication regimens enhances compliance.




Related Posts: